NDC 50090-0753

VALTREX

Valacyclovir Hydrochloride

VALTREX is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Valacyclovir Hydrochloride.

Product ID50090-0753_85a93d38-3584-4562-a98d-caa0d0cdf279
NDC50090-0753
Product TypeHuman Prescription Drug
Proprietary NameVALTREX
Generic NameValacyclovir Hydrochloride
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2002-08-12
Marketing CategoryNDA / NDA
Application NumberNDA020487
Labeler NameA-S Medication Solutions
Substance NameVALACYCLOVIR HYDROCHLORIDE
Active Ingredient Strength1 g/1
Pharm ClassesDNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 50090-0753-3

30 TABLET, FILM COATED in 1 BOTTLE (50090-0753-3)
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-0753-3 [50090075303]

VALTREX TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020487
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-11-28
Marketing End Date2018-01-31

Drug Details

Active Ingredients

IngredientStrength
VALACYCLOVIR HYDROCHLORIDE1 g/1

OpenFDA Data

SPL SET ID:477ec0ff-0319-40e2-a15d-4a89edde87ee
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 108780
  • 212448
  • 313564
  • 313565

    • Pharmacological Class

    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]

    NDC Crossover Matching brand name "VALTREX" or generic name "Valacyclovir Hydrochloride"

    NDCBrand NameGeneric Name
    0173-0565VALTREXvalacyclovir hydrochloride
    0173-0933VALTREXvalacyclovir hydrochloride
    50090-0753VALTREXVALTREX
    55289-926VALTREXVALTREX
    63629-3982VALTREXVALTREX
    70518-2039VALTREXVALTREX
    67296-0200VALTREXVALTREX
    0378-4275Valacyclovir Hydrochloridevalacyclovir hydrochloride
    0378-4276Valacyclovir Hydrochloridevalacyclovir hydrochloride
    0781-5208Valacyclovir HydrochlorideValacyclovir Hydrochloride
    0781-5209Valacyclovir HydrochlorideValacyclovir Hydrochloride
    0904-6565Valacyclovir HydrochlorideValacyclovir Hydrochloride
    10544-937valacyclovir hydrochloridevalacyclovir hydrochloride
    16714-697Valacyclovir HydrochlorideValacyclovir Hydrochloride
    16714-698Valacyclovir HydrochlorideValacyclovir Hydrochloride
    21695-832Valacyclovir HydrochlorideValacyclovir Hydrochloride
    21695-965Valacyclovir HydrochlorideValacyclovir Hydrochloride
    43063-200Valacyclovir HydrochlorideValacyclovir Hydrochloride

    Trademark Results [VALTREX]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VALTREX
    VALTREX
    74643955 2053301 Live/Registered
    GLAXOSMITHKLINE LLC
    1995-03-09
    VALTREX
    VALTREX
    74423957 1879098 Live/Registered
    GLAXOSMITHKLINE LLC
    1993-08-12
    VALTREX
    VALTREX
    74138827 not registered Dead/Abandoned
    CHEVRON CHEMICAL COMPANY
    1991-02-13
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.